AstraZeneca

Clovis, Tesaro Soar on Astrazeneca Phase Three News
TheStreet.com
Sat, 02/18/17 - 02:37 pm
Clovis Oncology
Tesaro
AstraZeneca
clinical trials
Lynparza
breast cancer
AstraZeneca Stock Rises On Successful Breast Cancer Drug Trial
TheStreet.com
Fri, 02/17/17 - 11:02 am
AstraZeneca
Lynparza
breast cancer
With Siliq approval, can Amgen and AZ's trash become Valeant's treasure?
Fierce Pharma
Thu, 02/16/17 - 10:11 am
Siliq
Amgen
AstraZeneca
Valeant Pharmaceuticals
chronic plaque psoriasis
Checkpoint inhibitors set to face off in bladder cancer
BioPharma Dive
Wed, 02/8/17 - 09:48 am
bladder cancer
Bristol-Myers Squibb
Opdivo
Merck
Keytruda
Roche
Tecentriq
AstraZeneca
durvalumab
AZ chief: Durvalumab's ready for a 'marketing battle' against I-O heavyweights Opdivo, Keytruda
Fierce Pharma
Tue, 02/7/17 - 10:25 am
immuno-oncology
AstraZeneca
durvalumab
Pascal Soriot
Merck
Keytruda
Bristol-Myers Squibb
Opdivo
Astrazeneca posts 4Q profit
Yahoo/AP
Thu, 02/2/17 - 09:26 am
AstraZeneca
earnings
Old drug gets new trick for prostate cancer treatment
Stat
Thu, 02/2/17 - 09:24 am
prostate cancer
AstraZeneca
ADT
bicalutamide
AstraZeneca’s Asthma Drug Receives Expanded Indication from FDA
Xtalks
Wed, 02/1/17 - 09:33 am
AstraZeneca
asthma
FDA
Symbicort
pediatrics
Earnings Preview: Merck set to solidify I/O lead, Sanofi still looking for deals and more
BioPharma Dive
Sat, 01/28/17 - 02:39 pm
Merck
Sanofi
Eli Lilly
Pfizer
Roche
AstraZeneca
Gilead Sciences
Allergan
GSK
AZ nabs 6 more months of Symbicort exclusivity—and the sales that come with it
Fierce Pharma
Fri, 01/27/17 - 09:28 am
AstraZeneca
Symbicort
exclusivity
pediatrics
asthma
AstraZeneca angles for more competitive position in immuno-oncology
BioPharma Dive
Thu, 01/19/17 - 11:19 am
AstraZeneca
immuno-oncology
tremelimumab
durvalumab
AstraZeneca delays PD-L1 data in rejig of phase 3 program
Fierce Biotech
Tue, 01/17/17 - 10:02 am
AstraZeneca
anti-PD-L1
clinical trials
tremelimumab
durvalumab
Biogen spinoff begins trading today; New oncology chief at AstraZeneca
Endpoints
Fri, 01/13/17 - 11:18 am
Biogen
AstraZeneca
oncology
hemophilia
Bioverativ
AstraZeneca CIO Makes IT Twice As Good At Half The Cost - Here Is How
Forbes
Tue, 01/3/17 - 11:49 am
Dave Smoley
AstraZeneca
IT
Label Expansion May Boost Revenues for AstraZeneca’s Tagrisso
Market Realist
Tue, 01/3/17 - 09:49 am
AstraZeneca
Tagrisso
non-small cell lung cancer
AstraZeneca’s Tagrisso Had a Strong Commercial Launch in 2016
Market Realist
Mon, 01/2/17 - 11:57 am
AstraZeneca
Tagrisso
non-small cell lung cancer
AstraZeneca Could See Modest Fall in 2016 Revenues
Market Realist
Sun, 01/1/17 - 11:34 am
AstraZeneca
PFE Completes Acquisition From AZN (PFE)
Investopedia
Sat, 12/24/16 - 12:15 pm
Pfizer
AstraZeneca
Zavicefta
Pfizer Completes Acquisition of Small Molecule Anti-Infective Business From AstraZeneca
Yahoo
Fri, 12/23/16 - 10:00 am
Pfizer
M&A
AstraZeneca
small molecule drugs
anti-infectives
Ionis Earns $28 Million from AstraZeneca for a New Drug to Treat Cancer
Yahoo
Fri, 12/16/16 - 09:45 am
Ionis
AstraZeneca
AZD4785
KRAS
cancer

Pages